Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
GLYCOBIOLOGY: Synthetic Vaccine Is a Sweet Victory for Cuban Science
Jocelyn Kaiser
On page 522, a Cuban-Canadian team reports the first large-scale production and clinical testing of a synthetic polysaccharide vaccine, one that targets the bacterium Haemophilus influenzae type B, a major cause of meningitis in young children.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
REPORTS
V. Verez-Bencomo, V. Fernández-Santana, Eugenio Hardy, Maria E. Toledo, Maria C. Rodríguez, Lazaro Heynngnezz, Arlene Rodriguez, Alberto Baly, Luis Herrera, Mabel Izquierdo, Annette Villar, Yury Valdés, Karelia Cosme, Mercedes L. Deler, Manuel Montane, Ernesto Garcia, Alexis Ramos, Aristides Aguilar, Ernesto Medina, Gilda Toraño, Iván Sosa, Ibis Hernandez, Raydel Martínez, Alexis Muzachio, Ania Carmenates, Lourdes Costa, Félix Cardoso, Concepción Campa, Manuel Diaz, and René Roy (23 July 2004) Science305 (5683), 522.
[DOI: 10.1126/science.1095209] |Abstract »|Full Text »|PDF »|Supporting Online Material »
